Ben Adams is an Author and Speaker at Field Sim. With a focus on the life safety industry and a deep expertise in healthcare technology and pharmaceuticals, he explores themes such as digital health, wellness programs, and mental health. Ben's insights and writings have been featured in notable publications including BuzzFeed, The Telegraph, and Fierce Pharma.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
Not enough data
Ben Adams primarily covers the health and pharmaceutical industries, focusing on corporate rebranding, drug advertising spending, regulatory petitions, and industry events. He also reports on healthcare-related initiatives and celebrity endorsements.
Given his focus on press releases and private sector announcements in the health and pharmaceutical industries, Ben is likely to be receptive to pitches that offer exclusive insights into major corporate developments within the sector. This could include new product launches or significant organizational changes within prominent companies.
Furthermore, given his coverage of regulatory petitions related to misleading promotions in the pharmaceutical industry, he may be interested in commentary from experts who can provide insight into legal or ethical issues surrounding healthcare marketing practices.
This information evolves through artificial intelligence and human feedback. Improve this profile .
By: Ben Adams
Johnson & Johnson looks set to continue battling AbbVie over ad spend in the second half of 2026 as the U.S.
The FDA has authorized Johnson & Johnson's Ottava Robotic Surgical System as it looks to compete with Intuitive Surgical and Medtronic.
Roche's Diagnostics division continues to battle growth headwinds, notching a 3% increase in sales.
The FDA has approved Freenome's new blood-based colorectal cancer test, SimpleScreen CRC, which Abbott will exclusively market in the U.S.
By: Ben Adams
Medical device maker Boston Scientific has been a prolific dealmaker this year but is now taking a step back as it looks to make changes internally.
By: Ben Adams
Colorectal cancer blood test maker Guardant Health has teamed up with “Grey's Anatomy” star Patrick Dempsey for a new, highly emotional video
Boston Scientific is cutting its financial guidance for the second quarter in a row as it gears up for a tough six months ahead.
GSK is boosting its AI chops with a new deal worth up to $110 million with Relation.
By: Ben Adams
Learn how a World Vision–supported reading club helped a young girl in Ghana gain confidence, literacy, and hope for the future.
By: Ben Adams
Changing patterns in fish stocks may drive uninfected migrating seals into rabid populations
